112 related articles for article (PubMed ID: 15466209)
1. Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2).
Perea SE; Reyes O; Puchades Y; Mendoza O; Vispo NS; Torrens I; Santos A; Silva R; Acevedo B; López E; Falcón V; Alonso DF
Cancer Res; 2004 Oct; 64(19):7127-9. PubMed ID: 15466209
[TBL] [Abstract][Full Text] [Related]
2. Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice.
Perera Y; Farina HG; Hernández I; Mendoza O; Serrano JM; Reyes O; Gómez DE; Gómez RE; Acevedo BE; Alonso DF; Perea SE
Int J Cancer; 2008 Jan; 122(1):57-62. PubMed ID: 17847034
[TBL] [Abstract][Full Text] [Related]
3. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
4. CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo.
Perea SE; Reyes O; Baladron I; Perera Y; Farina H; Gil J; Rodriguez A; Bacardi D; Marcelo JL; Cosme K; Cruz M; Valenzuela C; López-Saura PA; Puchades Y; Serrano JM; Mendoza O; Castellanos L; Sanchez A; Betancourt L; Besada V; Silva R; López E; Falcón V; Hernández I; Solares M; Santana A; Díaz A; Ramos T; López C; Ariosa J; González LJ; Garay H; Gómez D; Gómez R; Alonso DF; Sigman H; Herrera L; Acevedo B
Mol Cell Biochem; 2008 Sep; 316(1-2):163-7. PubMed ID: 18575815
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel antitumor peptide based on the screening of an Ala-library derived from the LALF(32-51) region.
Vallespi MG; Fernandez JR; Torrens I; Garcia I; Garay H; Mendoza O; Granadillo M; Falcon V; Acevedo B; Ubieta R; Guillen GE; Reyes O
J Pept Sci; 2010 Jan; 16(1):40-7. PubMed ID: 19908203
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells.
Harada H; Hiraoka M; Kizaka-Kondoh S
Cancer Res; 2002 Apr; 62(7):2013-8. PubMed ID: 11929818
[TBL] [Abstract][Full Text] [Related]
7. Enhanced binding of RNAP II CTD phosphatase FCP1 to RAP74 following CK2 phosphorylation.
Abbott KL; Renfrow MB; Chalmers MJ; Nguyen BD; Marshall AG; Legault P; Omichinski JG
Biochemistry; 2005 Mar; 44(8):2732-45. PubMed ID: 15723518
[TBL] [Abstract][Full Text] [Related]
8. A proapoptotic peptide for the treatment of solid tumors.
Mai JC; Mi Z; Kim SH; Ng B; Robbins PD
Cancer Res; 2001 Nov; 61(21):7709-12. PubMed ID: 11691780
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase CK2 catalyzes tyrosine phosphorylation in mammalian cells.
Vilk G; Weber JE; Turowec JP; Duncan JS; Wu C; Derksen DR; Zien P; Sarno S; Donella-Deana A; Lajoie G; Pinna LA; Li SS; Litchfield DW
Cell Signal; 2008 Nov; 20(11):1942-51. PubMed ID: 18662771
[TBL] [Abstract][Full Text] [Related]
10. Identification of peptides mimicking the ligands of proteins phosphorylated by protein kinase CK2.
Cardellini E; Felici F; Gianfranceschi GL
Peptides; 2004 Feb; 25(2):191-7. PubMed ID: 15063000
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis.
Channavajhala P; Seldin DC
Oncogene; 2002 Aug; 21(34):5280-8. PubMed ID: 12149649
[TBL] [Abstract][Full Text] [Related]
12. p53-dependent inhibition of mammalian cell survival by a genetically selected peptide aptamer that targets the regulatory subunit of protein kinase CK2.
Martel V; Filhol O; Colas P; Cochet C
Oncogene; 2006 Nov; 25(56):7343-53. PubMed ID: 16751801
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.
Franck N; Le Seyec J; Guguen-Guillouzo C; Erdtmann L
J Virol; 2005 Mar; 79(5):2700-8. PubMed ID: 15708989
[TBL] [Abstract][Full Text] [Related]
14. Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity.
Perera Y; Farina HG; Gil J; Rodriguez A; Benavent F; Castellanos L; Gómez RE; Acevedo BE; Alonso DF; Perea SE
Mol Cancer Ther; 2009 May; 8(5):1189-96. PubMed ID: 19417160
[TBL] [Abstract][Full Text] [Related]
15. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
Lee KW; Kim SG; Kim HP; Kwon E; You J; Choi HJ; Park JH; Kang BC; Im SA; Kim TY; Kim WH; Bang YJ
Cancer Res; 2008 Mar; 68(6):1916-26. PubMed ID: 18339873
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of Nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells.
Apopa PL; He X; Ma Q
J Biochem Mol Toxicol; 2008 Feb; 22(1):63-76. PubMed ID: 18273910
[TBL] [Abstract][Full Text] [Related]
17. A FRET-based microplate assay for human protein kinase CK2, a target in neoplastic disease.
Gratz A; Götz C; Jose J
J Enzyme Inhib Med Chem; 2010 Apr; 25(2):234-9. PubMed ID: 19874207
[TBL] [Abstract][Full Text] [Related]
18. Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cells.
Salvi M; Xu D; Chen Y; Cabrelle A; Sarno S; Pinna LA
Biochem Biophys Res Commun; 2009 Sep; 387(3):606-10. PubMed ID: 19616514
[TBL] [Abstract][Full Text] [Related]
19. BID, an interaction partner of protein kinase CK2alpha.
Olsen BB; Petersen J; Issinger OG
Biol Chem; 2006 Apr; 387(4):441-9. PubMed ID: 16606343
[TBL] [Abstract][Full Text] [Related]
20. TAT-RasGAP317-326 requires p53 and PUMA to sensitize tumor cells to genotoxins.
Michod D; Widmann C
Mol Cancer Res; 2007 May; 5(5):497-507. PubMed ID: 17510315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
